List of works - Laurie Galvan

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

scientific article published on 29 May 2013

Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugs.

scientific article published on 18 September 2009

CREB controls cortical circuit plasticity and functional recovery after stroke.

scientific article

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

scientific article published on 29 January 2016

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

scientific article published on 24 February 2012

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's Disease

scientific article

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease

scientific article published in January 2015

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease

scientific article

Hyposensitivity to the amnesic effects of scopolamine or amyloid beta(25-35) peptide in heterozygous acetylcholinesterase knockout (AChE(+/-)) mice.

scientific article published on 10 April 2008

JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse

scientific article

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

scientific article

Mitochondria in Huntington's disease

scientific article published on 11 August 2009

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models

scientific article published on April 2013

Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease

scientific article

Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease

scientific article published on 10 December 2018

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

scientific article

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.

scientific article published on 9 March 2018

List of works by Laurie Galvan

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugs.

CREB controls cortical circuit plasticity and functional recovery after stroke.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's Disease

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease

Hyposensitivity to the amnesic effects of scopolamine or amyloid beta(25-35) peptide in heterozygous acetylcholinesterase knockout (AChE(+/-)) mice.

JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

Mitochondria in Huntington's disease

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models

Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease

Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.